News

Net profit of Biofil Chemicals & Pharmaceuticals rose 5.00% to Rs 0.21 crore in the quarter ended March 2026 as against Rs 0.20 crore during the previous quarter ended March 2025. Sales declined 9.34% to Rs 7.57 crore in the quarter ended March 2026 as against Rs 8.35 crore during the previous quarter ended March 2025.For the full year,net profit rose 398.21% to Rs 2.79 crore in the year ended March 2026 as against Rs 0.56 crore during the previous year ended March 2025. Sales declined 14.97% to Rs 28.40 crore in the year ended March 2026 as against Rs 33.40 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales7.578.35 -9 28.4033.40 -15 OPM %5.681.32 -2.322.54 - PBDT0.540.34 59 3.731.12 233 PBT0.470.26 81 3.460.74 368 NP0.210.20 5 2.790.56 398 Powered by Capital Market - Live News

Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 May 2026.

Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live News

Net profit of Biofil Chemicals & Pharmaceuticals rose 300.00% to Rs 0.08 crore in the quarter ended September 2025 as against Rs 0.02 crore during the previous quarter ended September 2024. Sales rose 461.83% to Rs 13.54 crore in the quarter ended September 2025 as against Rs 2.41 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales13.542.41 462 OPM %0.894.98 - PBDT0.180.13 38 PBT0.110.03 267 NP0.080.02 300 Powered by Capital Market - Live News

Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live News